These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31739954)

  • 1. The Evolving Role of Radiotherapy for Head and Neck Cancer.
    Schwartz DL; Hayes DN
    Hematol Oncol Clin North Am; 2020 Feb; 34(1):91-108. PubMed ID: 31739954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy for head and neck cancer.
    Schwartz DL; Garden AS
    Hematol Oncol Clin North Am; 2006 Apr; 20(2):259-85. PubMed ID: 16730295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiochemotherapy in head and neck cancer.
    Merlano M; Marchetti G
    Cancer Treat Rev; 2003 Aug; 29(4):291-6. PubMed ID: 12927569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer.
    Fu KK; Cooper JS; Marcial VA; Laramore GE; Pajak TF; Jacobs J; Al-Sarraf M; Forastiere AA; Cox JD
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):425-38. PubMed ID: 8655364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in radiation therapy of head and neck cancer.
    Popovtzer A; Eisbruch A
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):633-44. PubMed ID: 18402530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial.
    Bartelink H; Van den Bogaert W; Horiot JC; Jager J; van Glabbeke M
    Eur J Cancer; 2002 Mar; 38(5):667-73. PubMed ID: 11916549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative Radiation Therapy for Head and Neck Cancers.
    Grewal AS; Jones J; Lin A
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):254-266. PubMed ID: 31128145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent chemoradiation in the treatment of head and neck cancer.
    Haffty BG
    Hematol Oncol Clin North Am; 1999 Aug; 13(4):719-42, vi-vii. PubMed ID: 10494509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel with concurrent radiotherapy in head and neck cancer.
    Nabell L; Spencer S
    Semin Oncol; 2003 Dec; 30(6 Suppl 18):89-93. PubMed ID: 14727247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous delivery of 5'-iododeoxyuridine during hyperfractionated radiotherapy for locally advanced head and neck cancers: results of a pilot study.
    Epstein AH; Lebovics RS; Van Waes C; Smith J; Okunieff P; Cook JA
    Laryngoscope; 1998 Jul; 108(7):1090-4. PubMed ID: 9665262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical results and experiences with combination of radiotherapy and radiosensitizing agents].
    Ikeda H
    Gan No Rinsho; 1990 Oct; 36(13):2244-7. PubMed ID: 1701197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of nimorazole as a hypoxic-cell sensitizer with the "chart" regimen in head and neck cancer.
    Cottrill CP; Bishop K; Walton MI; Henk JM
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):807-10. PubMed ID: 9845101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).
    Ghadjar P; Simcock M; Studer G; Allal AS; Ozsahin M; Bernier J; Töpfer M; Zimmermann F; Betz M; Glanzmann C; Aebersold DM;
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):524-31. PubMed ID: 21300466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitizers of photoradiation and ionizing radiation in the management of head and neck cancer.
    Lebovics RS; DeLaney TF
    Med Clin North Am; 1993 May; 77(3):583-96. PubMed ID: 8492611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma.
    Hassan Metwally MA; Ali R; Kuddu M; Shouman T; Strojan P; Iqbal K; Prasad R; Grau C; Overgaard J
    Radiother Oncol; 2015 Jul; 116(1):15-20. PubMed ID: 25913070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole.
    Hassan Metwally MA; Ali R; Kuddu M; Shouman T; Strojan P; Overgaard J; Grau C
    Acta Oncol; 2015; 54(9):1673-7. PubMed ID: 26397148
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiobiologic research for head and neck cancer therapy. Therapeutic implications.
    Weichselbaum RR; Rose CM; Ervin TJ; Miller D
    Arch Otolaryngol; 1983 Dec; 109(12):792-6. PubMed ID: 6357165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normobaric oxygen as a sensitizer in radiotherapy for advanced head and neck cancer.
    Zajusz A; Maciejewski B; Hliniak A
    Neoplasma; 1995; 42(3):137-40. PubMed ID: 7637824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming radioresistance in head and neck squamous cell carcinoma.
    Yamamoto VN; Thylur DS; Bauschard M; Schmale I; Sinha UK
    Oral Oncol; 2016 Dec; 63():44-51. PubMed ID: 27938999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising new advances in head and neck radiotherapy.
    Harari PM
    Ann Oncol; 2005; 16 Suppl 6():vi13-vi19. PubMed ID: 15987991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.